885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab

• Edward T Richardson,
• Geoffrey I Shapiro,
• Jennifer L Guerriero,
• Claudine Isaacs,
• Filipa Lynce,
• Madeline G Townsend,
• Kelly F Zheng,
• Paula R Pohlmann,
• Kenichi Shimada,
• Arielle Heeke,
• Xue Geng,
• Candace Mainor,
• Mei Wei,
• Julie M Collins,
• Lauren M Sloat,
• Jane Staunton,
• Stuart J Schnitt,
• Joan S Brugge,
• Hongkun Wang

Affiliations

Edward T Richardson

1 Harvard Medical School, Boston, Massachusetts, USA

Geoffrey I Shapiro

4Dana-Farber Cancer Institute, Boston, MA, USA

Jennifer L Guerriero

1Brigham and Women’s Hospital, Boston, MA, USA

Claudine Isaacs

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA

Filipa Lynce

4Dana-Farber Cancer Institute, Boston, MA, USA

Madeline G Townsend

1Brigham and Woman’s Hospital, Boston, MA, USA

Kelly F Zheng

1Brigham and Woman’s Hospital, Boston, MA, USA

Paula R Pohlmann

3The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Kenichi Shimada

3Division of Breast Surgery, Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA

Arielle Heeke

9Levine Cancer Institute, Charlotte, NC, USA

Xue Geng

5Georgetown University, Washington, DC, USA

Candace Mainor

7MedStar Georgetown University Hospital, Washington, DC, USA

Mei Wei

8University of Utah, Salt Lake City, UT, USA

Julie M Collins

5Georgetown University, Washington, DC, USA

Lauren M Sloat

2Harvard Medical School, Boston, MA, USA

Jane Staunton

2Harvard Medical School, Boston, MA, USA

Stuart J Schnitt

2Harvard Medical School, Boston, MA, USA

Joan S Brugge

2Harvard Medical School, Boston, MA, USA

Hongkun Wang

5Georgetown University, Washington, DC, USA